ESMO 2023 Summary: "Refining Risk Stratification in Patients Undergoing RT and Long-Term ADT for High-Risk/Locally Advanced Prostate Cancer"
By
Dana-Farber Cancer Institute
FEATURING
Praful Ravi
By
Dana-Farber Cancer Institute
FEATURING
Praful Ravi
Login to view comments.
Click here to Login